Загрузка...
Recombinant T Cell Receptor Ligand (RTL) Treats Experimental Stroke
BACKGROUND AND PURPOSE: Experimental stroke induces a biphasic effect on the immune response that involves early activation of peripheral leukocytes followed by severe immunodepression and atrophy of spleen and thymus. In tandem, the developing infarct is exacerbated by influx of numerous inflammato...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2704258/ https://ncbi.nlm.nih.gov/pubmed/19443805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.108.543991 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|